Add mass spectrometry to the pandemic toolbox

Bart Van Puyvelde; Maarten Dhaenens

doi:10.7554/eLife.75471

Add mass spectrometry to the pandemic toolbox

Elife. 2021 Dec 10:10:e75471. doi: 10.7554/eLife.75471.

Authors

Bart Van Puyvelde^{1

2}, Maarten Dhaenens^{1

2}

Affiliations

¹ Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.
² ProGenTomics, Ghent, Belgium.

Abstract

A new protocol step improves robustness and ease-of-use for mass spectrometry in the clinic, opening the door to mass deployment to monitor infectious agents.

Keywords: Covid-19; SARS-CoV-2; diagnostics; human; immunology; infectious disease; inflammation; mass spectrometry; microbiology; proteomics; public health.

Publication types

Editorial
Comment

MeSH terms

COVID-19*
Humans
Mass Spectrometry
Pandemics*
Proteomics
SARS-CoV-2